Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6414
    -0.0011 (-0.17%)
     
  • OIL

    83.03
    +0.30 (+0.36%)
     
  • GOLD

    2,395.30
    -2.70 (-0.11%)
     
  • Bitcoin AUD

    101,196.92
    +6,245.65 (+6.58%)
     
  • CMC Crypto 200

    1,328.33
    +15.70 (+1.20%)
     
  • AUD/EUR

    0.6022
    -0.0008 (-0.14%)
     
  • AUD/NZD

    1.0892
    +0.0017 (+0.16%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,830.93
    -46.12 (-0.59%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,684.27
    -153.13 (-0.86%)
     
  • Hang Seng

    16,245.82
    -140.05 (-0.85%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

United States Gout Market and Competitive Landscape Report 2017-2019 & 2020-2026

Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Gout Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

US Gout Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Gout pipeline products, Gout epidemiology, Gout market valuations and forecast, Gout drugs sales and competitive landscape in the US.

The research is classified into seven sections - Gout treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Gout pipeline: Find out the products in clinical trials for the treatment of Gout by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products

  • Gout epidemiology: Find out the number of patients diagnosed (prevalence) with Gout in the US

  • Gout drugs: Identify key products marketed and prescribed for Gout in the US, including trade name, molecule name, and company

  • Gout drugs sales: Find out the sales revenues of Gout drugs in the US

  • Gout market valuations: Find out the market size for Gout drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026

  • Gout drugs market share: Find out the market shares for key Gout drugs in the US

Benefits of this Research:

  • Support monitoring and reporting national Gout market analysis and sales trends

  • Track competitor drugs sales and market share in the US Gout market

  • Track competitive developments in Gout market and present key issues and learnings

  • Synthesize insights for Gout market and products to drive business performance

  • Answer key business questions about the Gout market

  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Gout products

  • Supports decision making in R&D to long term marketing strategies

ADVERTISEMENT

Key Topics Covered:

1) Gout Treatments

2) Gout Pipeline

3) US Gout Epidemiology

4) Marketed Drugs for Gout in US

5) US Gout Market Size and Forecast

6) US Gout Products Sales and Forecast

7) US Gout Market Competitive Landscape

8) Methodology

For more information about this report visit https://www.researchandmarkets.com/r/qg6sf4

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900